Comparing incidences of infusion site reactions between brand‐name and generic vinorelbine in patients with non‐small cell lung cancer-Reference-Cited by-同舟云学术

Comparing incidences of infusion site reactions between brand‐name and generic vinorelbine in patients with non‐small cell lung cancer

Published:2020-08-31 Issue:3 Volume:87 Page:1318-1326
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Ozawa Naoya¹^ORCID,Hase Tetsunari¹^ORCID,Hatta Takahiro¹,Sagara Atsunobu²,Ichikawa Kazuya²,Miyazaki Masayuki²,Yogo Naoyuki¹,Ando Masahiko³,Hashimoto Naozumi¹,Yamada Kiyofumi²,Hasegawa Yoshinori¹⁴

Affiliation:

1. Department of Respiratory Medicine Nagoya University Graduate School of Medicine Nagoya Japan

2. Department of Pharmacy Nagoya University Hospital Nagoya Japan

3. Centre for Advanced Medicine and Clinical Research Nagoya University Hospital Nagoya Japan

4. National Hospital Organization, Nagoya Medical Center Nagoya Japan

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14516

Reference24 articles.

1. Vinorelbine: A novel vinca alkaloid

2. High Body Mass Index Correlates with Increased Risk of Venous Irritation by Vinorelbine Infusion

3. Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer

4. Adjuvant Cisplatin and Vinorelbine for Completely Resected Non-small Cell Lung Cancer: Subgroup Analysis of the Lung Adjuvant Cisplatin Evaluation

5. Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 後発医薬品の継続的な品質改善に向けたジェネリック医薬品品質情報検討会の取り組み;Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences);2022-10-10